Sopharma AD (SPH)
GPW
10.80
+0.10 (+0.93%)
Closed
Oct 7, 2026
Day's Range
10.0010.80
52 wk Range
6.0412.75
Financial Statements - SPH - Sopharma AD
Revenue
1.32B▼ 37.6%
Net Income
69.58M▼ 13.5%Net Margin 5.2%
EBITDA
131.08M▼ 19.5%
Free Cash Flow
-63.26M▼ 41.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 1.32B | 2.12B | 1.87B | 1.66B | 1.60B | 1.43B |
| Cost of Goods | 1.01B | 1.67B | 1.46B | 1.30B | 1.26B | 1.13B |
| Gross Profit | 310.51M | 454.04M | 406.03M | 356.45M | 341.35M | 303.73M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 74.43M | 86.57M | 93.99M | 84.75M | 72.50M | 54.29M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 80.57M | 92.08M | 111.19M | 85.07M | 97.57M | 31.44M |
| Income Tax | 10.98M | 11.65M | 11.32M | 8.74M | 5.87M | 6.16M |
| Net Income | 69.58M | 80.43M | 99.87M | 76.33M | 91.70M | 25.28M |
| EPS Basic | 0.193542 | 0.46 | 0.73 | 0.59 | 0.71 | 0.24 |
| EPS Diluted | 0 | 0.46 | 0.69 | 0.57 | 0.71 | 0.24 |
| Basic Shares Outstanding | 175.47M | 164.25M | 130.69M | 121.49M | 59.11M | 59.29M |
| Diluted Shares Outstanding | 175.47M | 164.25M | 130.69M | 121.49M | 59.11M | 59.29M |
| Ebit | 91.69M | 106.52M | 121.41M | 91.09M | 108.36M | 43.85M |
| Ebitda | 131.08M | 162.83M | 171.29M | 151.86M | 142.80M | 98.84M |
| Net Income Continuous Operations | - | - | - | - | - | - |
| Minority Interests | -3.80M | -4.12M | -3.89M | -5.21M | -2.20M | 4.52M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
